Ames National Corporation (ATLO) confirmed earnings release on October 16, 2026, for the quarter ending September 30, 2026.The estimated EPS is $0.68The estimated revenue is $19300000 Price Impact of Stock Earnings Earnings Surprise Potential: If the actual earnings exceed market expectations, it could trigger a positive response from investors, leading to buying activity and a...
from Craig-Hallum issued a price target of $78.00 for ETON on 2026-10-15 13:20:51.The adjusted price target...
Anthony Hau from Truist Financial issued a price target of $19.00 for PINE on 2026-10-15 13:07:59.The...
from Industrial Alliance Securities issued a price target of $22.00 for VSTM on 2026-10-15 12:35:57.The adjusted...
Craig-Hallum analyst issues BUY recommendation for ETON on October 15, 2026 01:20PM ET. The previous analyst...
from Craig-Hallum issued a price target of $78.00 for ETON on 2026-10-15 13:20:51.The adjusted price target was set to $78.00.At the time of the announcement, ETON was trading at $54.58.The...
Anthony Hau from Truist Financial issued a price target of $19.00 for PINE on 2026-10-15 13:07:59.The adjusted price target was set to $19.00.At the time of the announcement, PINE was...
from Industrial Alliance Securities issued a price target of $22.00 for VSTM on 2026-10-15 12:35:57.The adjusted price target was set to $22.00.At the time of the announcement, VSTM was trading...
Steve Seedhouse from Cantor Fitzgerald issued a price target of $48.00 for ARQT on 2026-10-15 10:33:30.The adjusted price target was set to $48.00.At the time of the announcement, ARQT was...
from Wolfe Research issued a price target of $5.00 for OVID on 2026-10-15 10:11:03.The adjusted price target was set to $5.00.At the time of the announcement, OVID was trading at...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
